- Home
- APLM vs MNTS Comparison
APLM vs MNTS Comparison
Compare APLM & MNTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- MNTS
- Stock Information
- Founded
- APLM 2016
- MNTS 2017
- Country
- APLM United States
- MNTS United States
- Employees
- APLM N/A
- MNTS N/A
- Industry
- APLM Blank Checks
- MNTS Military/Government/Technical
- Sector
- APLM Finance
- MNTS Industrials
- Exchange
- APLM Nasdaq
- MNTS Nasdaq
- Market Cap
- APLM 6.9M
- MNTS 6.6M
- IPO Year
- APLM N/A
- MNTS N/A
- Fundamental
- Price
- APLM $6.14
- MNTS $1.15
- Analyst Decision
- APLM
- MNTS
- Analyst Count
- APLM 0
- MNTS 0
- Target Price
- APLM N/A
- MNTS N/A
- AVG Volume (30 Days)
- APLM 7.8K
- MNTS 3.3M
- Earning Date
- APLM 08-13-2025
- MNTS 05-15-2025
- Dividend Yield
- APLM N/A
- MNTS N/A
- EPS Growth
- APLM N/A
- MNTS N/A
- EPS
- APLM N/A
- MNTS N/A
- Revenue
- APLM $198,000.00
- MNTS $1,923,000.00
- Revenue This Year
- APLM $415.15
- MNTS $286.00
- Revenue Next Year
- APLM N/A
- MNTS N/A
- P/E Ratio
- APLM N/A
- MNTS N/A
- Revenue Growth
- APLM N/A
- MNTS N/A
- 52 Week Low
- APLM $4.47
- MNTS $1.03
- 52 Week High
- APLM $35.98
- MNTS $28.56
- Technical
- Relative Strength Index (RSI)
- APLM 47.85
- MNTS 29.65
- Support Level
- APLM $6.21
- MNTS $1.03
- Resistance Level
- APLM $6.80
- MNTS $1.90
- Average True Range (ATR)
- APLM 0.52
- MNTS 0.16
- MACD
- APLM 0.00
- MNTS -0.02
- Stochastic Oscillator
- APLM 51.61
- MNTS 9.60
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About MNTS Momentus Inc.
Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.